ESC Professional Premium Access

The triglyceride-glucose index might be a better indicator for predicting poor cardiovascular outcomes in chronic coronary syndrome

Congress Presentation

About the speaker

Doctor Duygu Inan

Basaksehir Çam ve Sakura Sehir HastanesiBasaksehir Cam ve Sakura Sehir Hastanesi, Istanbul (Türkiye)
1 follower

6 more presentations in this session

Does prediabetes diagnosed by hemoglobinA1c or oral glucose tolerance test predict coronary artery disease in patients suspected of chronic coronary syndrome?

Speaker: Doctor K. Overgaard (Svendborg, DK)


Real-life use of novel glucose lowering agents after acute myocardial infarction and stable coronary artery disease in patients with diabetes - experience from national use in the SWEDEHEART-registry

Speaker: Doctor V. Ritsinger (Stockholm, SE)


Vessel-oriented cardiovascular events in patients with diabetes undergoing intracoronary physiology-guided revascularization

Speaker: Doctor S. Sgreva (Verona, IT)


Synergistic adverse impact of diabetes and chronic kidney disease on cardiovascular mortality in patients underwent percutaneous coronary intervention

Speaker: Doctor S. Moriya (Tokyo, JP)


Diabetes mellitus and response to IL-1 blockade with Anakinra after ST-elevation myocardial infarction: a pooled analysis of the VCU-ART studies

Speaker: Doctor F. Moroni (Charlottesville, US) Doctor A. Abbate (Charlottesville, US)


Access the full session

Diabetes and stable coronary artery disease

Speakers: Doctor D. Inan, Doctor K. Overgaard, Doctor V. Ritsinger, Doctor S. Sgreva, Doctor S. Moriya...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by